Latest News

Tourmaline Bio (TRML) is back in the headlines, and if you have been watching the stock, you might be wondering if this latest move is a meaningful signal or just another blip. With no major event triggering the activity, investors are left sifting through what is driving momentum. Sometimes, mere price action alone can prompt questions about whether the market is seeing something others are missing. Over the past year, Tourmaline Bio has seen strong gains, climbing 147%. Momentum has...

Are you puzzling over what to do with Air France-KLM shares after the rollercoaster year they have had? You are definitely not alone. Whether you already have the airline in your portfolio or you are circling it as a potential buy, there is a lot to unpack when it comes to this company. Its valuation story is especially intriguing right now. Let’s start with how the stock has been behaving. Over the past year, Air France-KLM has soared, returning nearly 57%, and it is up even further, by more...

If you have Morinaga&Co on your radar, you are probably wondering whether it is time to buy, sell, or hold. The stock has held steady over the past week, but zoom out for a moment and the picture gets a lot more interesting. Over the last month, there was a 3.7% climb in price, following broader optimism about Japan's consumer goods sector and a handful of upbeat regional economic updates. However, some investors are still digesting longer-term risks, as reflected in the almost flat...

Trying to figure out what to do with Alma Media Oyj stock right now? You are not alone. With its shares closing at 14.65, a lot of investors are weighing up what comes next. Over the past year, Alma Media Oyj’s stock price has soared 38.2%, including a robust 30.2% climb year-to-date. Zoom out a bit further, and the growth story looks even stronger. The stock is up 87.2% in three years and an impressive 132.7% over five years. Even just in the last month, the stock gained nearly 10% as...

Boss Energy Limited has initiated a comprehensive operational review of its Honeymoon uranium project in South Australia, focusing on assessing production capacity, mineralisation continuity, and leachability, with expert input and accelerated drilling underway since late July 2025. This proactive review signals management’s commitment to rigorously reassessing project assumptions laid out in the 2021 enhanced feasibility study, addressing market concerns about production challenges. With...

Deciding what to do with Koei Tecmo Holdings (TSE:3635) right now means weighing the impact of a major new event. The company just announced a plan to raise capital by disposing of treasury shares and conducting a secondary public offering, together with adjustments to its share acquisition rights. Moves like these can reshape both the company's financial position and how investors view its future, especially when the stated goal is to boost the capital base and unlock shareholder value. This...

If you have ever found yourself staring at China Petroleum & Chemical’s ticker and wondering if now is the right time to buy, hold, or move on, you are definitely not alone. This is a stock that has kept investors on their toes, juggling cycles of volatility and hints of long-term promise. Over the last year, the share price has gained 3.2%. If we stretch the timeline to five years, the stock has more than doubled, up an impressive 102.6%. That said, price swings in the shorter term can be...

In the past week, Century Aluminum was upgraded to a Zacks Rank #1 (Strong Buy) after analysts raised full-year earnings estimates by 15.7%, signalling improved forecast expectations. This shift in sentiment highlights growing analyst confidence in the company’s ability to capitalize on sector trends and outperform industry peers. We'll explore how this heightened analyst outlook may influence Century Aluminum's investment narrative, especially in light of its expansion efforts. AI is about...

Braze, Inc. recently announced its second quarter fiscal 2025 results, reporting sales of US$180.11 million and an increased net loss of US$27.9 million compared to the same period last year. While revenue continued to grow, the updated guidance projects annual sales between US$717.0 million and US$720.0 million, offering fresh insight into management’s expectations for the remainder of the fiscal year. We'll assess how Braze's updated revenue outlook for the year may influence its...

HA Sustainable Infrastructure Capital recently reported a strong second quarter, with revenues surpassing analyst expectations by 32.1% due to its investments in climate-positive infrastructure projects. This performance highlights how the company's focus on sustainable infrastructure is playing a central role in driving revenue growth beyond market forecasts. We'll now explore how HA Sustainable Infrastructure Capital's climate-positive investments are shaping its current investment...

Thinking about what to do with Crescent Energy (CRGY) after its recent surge? Investors have taken notice as shares jumped 5.8%, powered by strong commodity prices and Crescent’s established foothold in major U.S. basins like Eagle Ford and Uinta. While its mix of low-cost production assets looks like a winning formula for profitability, the story has gotten more complicated lately as downward revisions to expected earnings per share have clouded the outlook just as momentum seemed to be...

Thinking about what to do with Shimizu stock? You are definitely not alone. After a jaw-dropping 121.7% leap over the past year and an impressive 4.3% rise in just the last week, investors everywhere are eyeing this construction giant with renewed interest. If you had held on for five years, you would have more than tripled your money. That is the kind of performance that turns cautious glances into real portfolio consideration. So, what has powered this surge? Some of it can be attributed to...

Shibaura Mechatronics (TSE:6590) has caught the eye of many investors recently after its shares finished the day unchanged. While a flat move might not spark excitement, it does invite a closer look, especially for those considering whether to hold, buy, or move on in the current market landscape. Sometimes, a quiet session says as much about market sentiment as a major swing. This often prompts investors to dig deeper into what is driving the stock and to question whether stability is a...

NOK (TSE:7240) has recently moved higher, catching the attention of investors who are weighing what’s next for the Japanese auto parts maker. There is no specific news event driving the action, which makes the uptick all the more interesting, especially for those who keep an eye out for subtle market signals rather than flashy headlines. Sometimes, these quieter periods can offer a window into how market participants are pricing in expectations, and whether there is a story gathering steam...

Applied Materials announced in the past week that its Board of Directors approved a quarterly cash dividend of $0.46 per share, payable on December 11, 2025, to shareholders of record as of November 20, 2025. This move marks an eighth consecutive year of dividend increases for the company, underscoring strong financial performance and an ongoing commitment to shareholder returns, with dividends rising at an annual compound growth rate of 15% over the past decade. We will now explore how this...

Is Arjo (OM:ARJO B) Hiding Value or Are Markets Right? If you have Arjo (OM:ARJO B) on your radar, a recent shift in the stock may have caught your eye. While there hasn’t been a single headline-grabbing event, sometimes steady moves say as much as any major announcement. These quieter moments can raise a straightforward question for investors: are we looking at the start of something, or is the market simply taking a breather as it reassesses? Looking at the numbers, Arjo has seen a slight...

Are you wondering what to make of DexCom’s stock these days? You are definitely not alone. Investors have watched DexCom move through a string of changes, with its shares closing recently at $76.22. After a dip of 5.3% in the past week and 5.8% over the last month, it is natural to question whether this is an opportunity in disguise. Even with a negative return so far this year, DexCom stock is up nearly 10% compared to a year ago, a sign that there is still faith in the company’s growth...

Allison Transmission recently announced that its Neutral at Stop fuel-saving technology is now standard on Kenworth and Peterbilt models equipped with the Allison 4700 Rugged Duty Series™ transmissions, targeting enhanced fuel efficiency in commercial fleets. This move is expected to deliver direct operational benefits for urban and stop-start fleet operators, supporting lower fuel consumption and advancing sustainability goals within the industry. We'll examine how the standardization of...

PagSeguro Digital Ltd. recently announced a special dividend of US$0.12 per share, payable on November 3, 2025, with an ex-date and record date of October 6, 2025. This special dividend underlines the company’s approach to capital allocation and signals management’s confidence in PagSeguro’s financial position. To assess its impact, we'll explore how this special dividend announcement shapes PagSeguro Digital’s investment case and shareholder value proposition. Find companies with promising...

Southwest Gas Holdings (SWX) just wrapped up the sale of its entire stake in Centuri Holdings, a move that is turning heads among investors. By cashing out of Centuri, Southwest Gas is aiming to zero in on its bread-and-butter utility business, providing a clear signal about where leadership sees future value. Shortly after completing the sale, the stock caught an upgrade from BofA Securities, with analysts citing an improved risk/reward balance and new focus on the company’s core...

In early September 2025, Eli Lilly announced positive Phase 3 results for Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia and launched Lilly TuneLab, an advanced AI/ML platform for drug discovery, with additional strategic collaborations unveiled by partners such as insitro and Circle Pharma. The combination of new clinical data and the introduction of AI-driven drug development models underscores Lilly's expanding innovation capabilities and commitment to accelerating R&D...

If you are weighing your next move with Glory stock, you are in good company. The past year has been anything but dull for Glory. After all, not every stock can claim a 54.8% jump in twelve months or an 88.5% climb over the past three years. Even in the past month, the stock notched a respectable 2.6% gain, hinting at underlying optimism or perhaps a shift in how the market is viewing Glory's future prospects. The year-to-date performance, up 48.1%, is hard to ignore and may reflect broader...

Thinking about what to do with your Fagron shares, or maybe just eyeing the stock with curiosity? You are not alone. With the price sitting at €20.8 after a year where it returned 10.3%, investors are rightly weighing whether this specialist in pharmaceutical compounding has more room to run. In fact, if you zoom out, the stock has climbed 60.4% over the past three years and 24.1% just year-to-date. Recent weeks have been more muted, with a dip of -1.2% over seven days and a modest 0.5% gain...

Melius Research recently initiated coverage on EOG Resources, assigning a Buy rating and highlighting the company’s disciplined focus on internal growth and technology for cost reduction. The report also drew attention to EOG Resources’ 36-year record of consistent dividends and its leadership in U.S. shale production regions. We’ll examine how the spotlight on EOG’s technology-driven efficiency could influence the company’s broader investment narrative. The latest GPUs need a type of rare...